CXCL8 and neoplasm: In a mouse model of thyroid cancer, the treatment with thyroid-stimulating hormone increased the production of VEGF-A and CXCL8 from tumor cells resulted in the recruitment of F4/80+ macrophages and in supporting angiogenesis and tumor growth [162].